Effects of low-dose niacin on dyslipidemia and serum phosphorus in patients with chronic kidney disease

Hyo-Jin KANG; Do-Kyong KIM; Su-Mi LEE; Kyung-Han KIM; Seung-Hee HAN; Ki-Hyun KIM; Seong-Eun KIM; Young-Ki SON; Won-Suk ANN.
Kidney Research and Clinical Practice ; : 21-26, 2013.
Artigo em Inglês | WPRIM | ID: wpr-142112

Documentos relacionados

  1. Effects of niacin on apo A1 and B levels: a systematic review and meta-analysis of randomised controlled trials.
  2. Test for abnormal niacin response syndrome in schizophrenia: reclaiming the oral route
  3. Effects of niacin supplementation during in vitro culture on the developmental competence of porcine embryos.
  4. Synthesis of Mixed Dinucleotides by Mechanochemistry.
  5. Total Synthesis of Euonymine and Euonyminol Octaacetate.
  6. Niacin: a long history, but a questionable future.
  7. [Seminal plasma exosomes and sperm DNA fragmentation index: A metabolomics analysis].
  8. Reply: Niacin therapy improves outcome and normalizes metabolic abnormalities in an NAXD-deficient patient.
  9. Niacin therapy improves outcome and normalizes metabolic abnormalities in an NAXD-deficient patient.
  10. Novel Ascorbic Acid Co-Crystal Formulations for Improved Stability.